AccuDial Pharmaceutical, Inc. Acquires Spinformation/Stephen Key Design, LLC. PALM BEACH GARDENS, FL (October 4, 2011) – AccuDial Pharmaceutical, Inc. has acquired Stephen Key Design, LLC. This acquisition expands AccuDial’s patent portfolio to over 50 patents for weight-based dosing and other extended content rotating labels (ECRL), which adds 75% more labeling space to a container. more...
AccuDial Recommendations for Safer and Effective Dosing to Pediatric Acetaminophen Advisory Committee PALM BEACH GARDENS, FL (May 19, 2011) – Underscoring the importance of weight-based dosing for over-the-counter (OTC) children’s acetaminophen medications, AccuDial Pharmaceutical, Inc. made seven recommendations to the Food & Drug Administration (FDA) at the meeting of the Joint Pediatric Advisory Committee and Non-Prescription Drugs Advisory Committee on Tuesday, May 17, 2011 concerning children’s single-ingredient acetaminophen products. more...
Children’s AccuDial Named Edison Awards Finalist PALM BEACH GARDENS, FL (February 15, 2011) – Children’s AccuDial is a finalist in the Consumer Packaged Goods category, one of 12 categories honored by the Edison Awards. The distinguished awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring America’s drive to remain in the forefront of innovation, creativity, and ingenuity in the global economy. more...
AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children’s Liquid Medications PALM BEACH GARDENS, FL (December 13, 2010) – The national media is ringing the alarm on the disturbing results of the NYU one-year research study on pediatric dosing instructions on liquid medication, which is reported in the Journal of the American Medical Association’s December issue. The results are shocking. more...
Parents Put Children in Danger by Misdosing Medication PALM BEACH GARDENS, FL (September 21, 2010) – Parents’ confusion over correctly administering over-the-counter medications to their children appears to be shared worldwide, according to a study presented this week in Lisbon by Dr. Rebekah Moles… more...
AccuDial® Pharmaceutical, Inc. Joins CHPA Task Force PALM BEACH GARDENS, FL (August 9, 2010) – AccuDial® Pharmaceutical, Inc. joins eight of the top over-the-counter (OTC) pediatric manufacturers as part of the Consumer Healthcare Products Association (CHPA) Pediatric Cough/Cold Ingredient Efficacy Research Task Group. The task force, which formed in February 2010, also includes Boehringer Ingelheim Pharmaceuticals, Inc., Novartis Consumer Health, Inc., McNeil Consumer Healthcare Division of McNeil-PPC, Inc., Perrigo Company, The Procter & Gamble Company, Reckitt Benckiser Inc., and Wyeth LLC participating through Pfizer Consumer Healthcare. more...
Christopher Vounasis to Oversee AccuDial® Pharmaceutical, Inc.’s Canadian Operations PALM BEACH GARDENS, FL (July 15, 2010) – Christopher Vounasis has been named Director of Canadian Sales & Marketing by AccuDial® Pharmaceutical, Inc. Vounasis joins AccuDial from PendoPharm, the OTC division of one of the largest Canadian generic pharmaceutical manufacturers, Pharmascience Inc., where he worked for seven years. more...
AccuDial® Pharmaceutical Appoints Industry Leaders to Board of Directors PALM BEACH GARDENS, FL (June 30, 2010) – AccuDial Pharmaceutical, Inc. announced today the expansion of its board of directors with the appointment of five distinguished industry leaders. With the exciting success of its Children’s AccuDial family of pediatric, over-the-counter (OTC) products, which launched in Canada in January 2010, the private pharmaceutical company is moving forward aggressively in the dynamic global market. more...
AccuDial Pharmaceutical Closes $4 Million Funding PALM BEACH GARDENS, FL (March 3, 2010) – AccuDial® Pharmaceutical, Inc. announced today that their initial financing, a private placement for four million shares at $1 per share, has been successfully closed. This funding round was accomplished entirely by AccuDial’s management team and board of directors without any institutional involvement. more...
Weight-based Dosing Now Available for Canadian Children PALM BEACH GARDENS, FL (January 28, 2010) – AccuDial® Pharmaceutical, Inc. delivered a power-packed launch with their new family of eight over-the-counter (OTC) medications in Canada. Colorful floor displays enjoyed prominent placement in every Quebec Walmart pharmacy, and were filled with AccuDial’s pain and fever, allergy, and cough and cold pediatric medications. more...
Congressman Ron Klein Listens to Florida Moms PALM BEACH GARDENS, FL (September 1, 2009) – AccuDial Pharmaceutical, at the request of Klein’s office, hosted the briefing to introduce their new, patented, two-part rotating label that provides dosing for children based on a child’s weight, not age. more...
Where the FDA Experts Question, AccuDial Has the Answer PALM BEACH GARDENS, FL (July 2, 2009) – AccuDial Pharmaceutical, Inc. has come up with a solution to one of the issues a federal advisory panel of experts had gathered to review associated with popular, over-the-counter pain relievers such as acetaminophen. more...
AccuDial Awarded Best New Product at ECRM PALM BEACH GARDENS, FL (March 13, 2009) – Over 150 retailers and manufacturers attended the Efficient Collaborative Retail Marketing (ECRM) Cough & Cold and Allergy show in Jacksonville, Fla., at the beginning of March. The show hosted more than 80 manufacturers and some 90 retailers. A variety of new products were introduced at the show where retailers voted AccuDial Pharmaceutical “BEST NEW PRODUCT.” more...
Health Canada Approves Revolutionary OTC Dosing System PALM BEACH GARDENS, FL (January 6, 2009) – Health Canada has approved two of AccuDial Pharmaceutical, Inc.’s over-the-counter (OTC) pediatric medications. AccuDial’s medications feature the first weight-based dosing system that allows caregivers to accurately administer over-the-counter medications to children. more...
Brazilian Patent Office Issues Patent for AccuDial Pharmaceutical Dosing System PALM BEACH GARDENS, FL (December 2, 2008) – AccuDial Pharmaceutical announced today that the Brazilian Patent and Trademark Office has issued patent No. 0108453-4, relating to a device for calculating therapeutically correct doses of liquid medications based on a patient’s weight instead of age. more...
FDA Cites Dosing Errors in New Recommendations for Children’s OTC Medications PALM BEACH GARDENS, FL (October 14, 2008) – Underscoring the importance of weight-based dosing for over-the-counter (OTC) children’s medications, the Food and Drug Administration (FDA) recently announced its recommendation that cold and cough medications be relabeled: “For Children Ages 4 and Up.” more...
top of page